Cheng-fang Tsai
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Corrigendum to "Ubiquinol ameliorates social disruption-induced behavioral changes via modulating inflammatory responses and PPARα activation" [Behav. Brain Res. 508 (2026), 116215].
Journal: Behavioural brain research
Published: June 16, 2026
Poly(I:C)-stimulated alveolar macrophages modulate extracellular matrix turnover and fibroblast activation through cystatin 6 and cathepsin B.
Journal: European journal of pharmacology
Published: February 21, 2026
Ubiquinol ameliorates social disruption-induced behavioral changes via modulating inflammatory responses and PPARα activation.
Journal: Behavioural brain research
Published: February 05, 2026
Lumbrokinase modulates tissue plasminogen activator and alleviates behavioral and cognitive deficits in mice with chronic social defeat stress.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 22, 2025
Protective effects of dihydroartemisinin against sterile inflammation and oxidative stress in alveolar macrophages.
Journal: Biochimica et biophysica acta. General subjects
Published: October 05, 2025
Oral administration of osthole mitigates maladaptive behaviors through PPARα activation in mice subjected to repeated social defeat stress.
Journal: Neurochemistry international
Published: May 15, 2024
Fenofibrate Inhibits LPS and Zymosan-induced Inflammatory Responses through Sonic Hedgehog in IMG Cells.
Journal: Current molecular pharmacology
Published: April 20, 2024
Protective effects of paeonol against cognitive impairment in lung diseases.
Journal: Journal of pharmacological sciences
Published: February 16, 2024
Ramelteon protects against social defeat stress-associated abnormal behaviors.
Journal: Pharmacology, biochemistry, and behavior
Published: January 31, 2024
Repetitive Administration of Low-Dose Lipopolysaccharide Improves Repeated Social Defeat Stress-Induced Behavioral Abnormalities and Aberrant Immune Response.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: January 30, 2024
Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers.
Journal: Toxicology and applied pharmacology
Published: September 12, 2023
Last Updated: 09/26/2026